Our Mission
Amplify51 Limited is a not-for-profit organisation committed to improving the health and wellbeing of women by promoting investment in women’s health. Our goal is to accelerate research and translation of discoveries in prevention, diagnosis and treatment to address unmet needs in women’s health and close the gender health gap.
“For all the efforts to improve gender equity over the past century, the gap between men’s health and women’s health remains wide, whether it’s in research, data, care or investment.”
Source: World Economic Forum 2024 In collaboration with the McKinsey Health Institute: Closing the Women's Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies, Insight Report Jan 2024
The Challenge
There is a significant gap in clinical understanding of women’s health.
01
51% of the Australian population identify as women, yet medicine has historically treated the male body as the standard. Women were largely excluded from medical trials for decades because of concerns around pregnancy risks and because scientists thought their hormonal changes would make study results less reliable. This has created a significant gap in clinical understanding of women’s health that persists today.
Women’s health strategies are often narrowly focused on reproductive and gynaecological care.
02
Women’s health is not limited to conditions that only affect women. Many common diseases - including cardiovascular disease, osteoporosis and Alzheimer’s disease - affect women differently and in some cases disproportionately. The result is that research and treatments tailored to women remain limited.
The data gap - stemming from the limited clinical understanding and the narrow focus of women’s health strategies - is compounding the disparity in health outcomes.
03
Delayed or misdiagnoses of diseases, less-effective treatments, and missed prevention opportunities mean women’s health needs are not seen, recorded, measured, prioritised or planned for. When research results and clinical data don’t reflect experiences of 51% of the population future planning of healthcare systems, reimbursement programs and analysis of market demand for therapeutics and services will be flawed.
The Opportunity
Women exert a substantial impact on national economies - they make up of half the population, half the workforce, hold two-thirds of the wealth, and make the majority of household spending decisions. Resolving their unmet medical needs and maximising their wellbeing and productivity should be a national strategic priority.
Many therapies already target conditions that affect women uniquely, differently, or disproportionately, yet are developed and commercialised with male biology as the default, limiting efficacy, adoption, and market reach. Addressing this gap creates a powerful lever for optimising existing assets.
Multiple recent global reports estimate that addressing the historically ignored broader therapeutic areas for women could unlock a multi-billion-dollar market opportunity.
With their health needs recognised and addressed, women will be better positioned to thrive - in education, in family life, in the workforce and in leadership generally - allowing them to live more fully throughout all stages of their lives and facilitating gender equity more broadly.
“Investments addressing the women’s health gap could add years to life and life to years - and potentially boost the global economy by $1 trillion annually by 2040.”
Source: World Economic Forum 2024 In collaboration with the McKinsey Health Institute: Closing the Women's Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies, Insight Report Jan 2024.